Your Location：
Home >
Browse articles >
Effect of Kangliu Zengxiao Formula Combined with Gefitinib in Treating Elderly Non-small Cell Lung Cancer and on Inflammation Factors, Level of T Cell Subsets and Serum Tumor Markers
Effect of Kangliu Zengxiao Formula Combined with Gefitinib in Treating Elderly Non-small Cell Lung Cancer and on Inflammation Factors, Level of T Cell Subsets and Serum Tumor Markers
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 7, Pages: 173-178(2017)
DOI： 10.13422/j.cnki.syfjx.2017070173
Scan QR Code
Full Text(HTML)
References
Publication Info
Metrics
71
Views
51
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Yifei Zhuji Formula Reverses Epithelial-mesenchymal Transition of Non-small Cell Lung Cancer by Regulating PI3K/Akt/mTOR Signaling Pathway
Graphene-mediated Far-infrared Therapy Enhances Anti-non-small Cell Lung Cancer Effects of Panax quinquefolium Saponins via cGAS/STING Signaling Pathway
Syndrome Differentiation and Treatment Strategies for NSCLC Immunotherapy from Perspective of Qi-Fire in Five Zang-Organs Based on Theory of Distance of Lung Fire
Mechanisms of Salvianolic Acid B in Inhibiting Epithelial-mesenchymal Transition in Non-small Cell Lung Cancer by Downregulating PAICS Expression
Eupatilin Inhibits Proliferation， Invasion， and Metastasis of Non-small Cell Lung Cancer via EZH2/H3K27me3 Signaling Pathway
Related Author
LI Jiarui
ZHANG Na
LIU Xuefang
WANG Qi
ZHAO Di
FENG Suxiang
YANG Zijiang
ZANG Huifang
Related Institution
School of Medicine，Henan University of Chinese Medicine
Academy of Chinese Medical Sciences， Henan University of Chinese Medicine
Shandong Key Laboratory of Digital Traditional Chinese Medicine， Institute of Pharmacy， Shandong University of Traditional Chinese Medicine
Shandong Medical and Pharmaceutical University
Guang'anmen Hospital， China Academy of Chinese Medical Sciences
Chat
